Takeda Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Takeda Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Takeda Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Takeda Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Takeda Pharmaceutical Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Takeda Pharmaceutical Co Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Julie Kim
President; Director; Chief Executive Officer Executive BoardMrs. Julie Kim has been the Chief Executive Officer, Director, and President of the company since June 2026. Previously, she served as President of the Plasma Delivered Therapies Business Unit of the company. Previously, he served as the President of the US Business Unit of the company.
Milano Furuta
Director; Chief Financial Officer Executive BoardMr. Milano Furuta has been the Director and Chief Financial Officer of the company since 2024. Prior to this, he served as the President of Takeda’s Japan Pharma Business Unit from April 2021 to March 2024. Mr. Furuta also served as the Corporate Strategy Officer and Chief Of Staff at Takeda. Previously, he served as an Equity Research Analyst at an investment management firm in the US.
Gabriele Ricci
Chief Technology Officer; Chief Data Officer Senior ManagementMr. Gabriele Ricci has been the Chief Data Officer and Chief Technology Officer of the company since 2022. Prior to this, he served as the Head of IT for the Plasma-Derived Therapies Business Unit. Previously, he served as the Head of Technical Operations at Shire.
Jennifer Smoor
Chief Governance Officer; Chief Communications Officer Senior ManagementMr Jennifer Smoor has been the Chief Communications Officer and Chief Governance Officer of the company since 2026. Prior to this, she served as the Chief Communications Officer at UnitedHealth Group. Previously, she served as the External Affairs Officer at Interior Therapeutics.
Awny Farajallah
Chief Medical Officer Senior ManagementMr Awny Farajallah serves as the Chief Medical Officer of the company. Prior to this, he served as the Head of Global Medical Affairs Oncology of the company. Previously, he served as the Senior Vice President of Medical Affairs in North America at Ipsen. Mr Farajala also served as the Head and Vice President of U.S. Medical Affairs at Bristol Myers Squibb.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer